Concepedia

Publication | Open Access

Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America

DOIFull Paper Access

1.2K

Citations

12

References

2007

Year

Donna M. Weber, Christine Chen, Rubén Niesvizky, Michael Wang, Andrew R. Belch, Edward A. Stadtmauer, David S. Siegel, Ivan Borrello, S. Vincent Rajkumar, Asher Chanan‐Khan,
New England Journal of Medicine

Abstract

Lenalidomide plus dexamethasone is superior to placebo plus dexamethasone in patients with relapsed or refractory multiple myeloma. (ClinicalTrials.gov number, NCT00056160 [ClinicalTrials.gov].).

References

YearCitations

Page 1